Open access
328
Views
0
CrossRef citations to date
0
Altmetric
Brief Report
Therapeutic efficacy of RAS inhibitor trametinib using a juvenile myelomonocytic leukemia patient-derived xenograft model
Alex Q. Leea Department of Pediatrics, UC Davis School of Medicine, Sacramento, California, USAView further author information
, Hiroaki Konishia Department of Pediatrics, UC Davis School of Medicine, Sacramento, California, USAView further author information
, Masami Ijiria Department of Pediatrics, UC Davis School of Medicine, Sacramento, California, USAView further author information
, Yueju Lib Department of Public Health Sciences, UC Davis, Davis, California, USAView further author information
, Arun Panigrahia Department of Pediatrics, UC Davis School of Medicine, Sacramento, California, USAView further author information
, Jeremy Chienc Department of Biochemistry and Molecular Medicine, UC Davis School of Medicine, Sacramento, California, USAView further author information
& Noriko Satakea Department of Pediatrics, UC Davis School of Medicine, Sacramento, California, USACorrespondence[email protected]
https://orcid.org/0000-0002-8713-2529View further author information
show allhttps://orcid.org/0000-0002-8713-2529View further author information
Received 03 Nov 2023, Accepted 29 Feb 2024, Published online: 22 Apr 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.